Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers…
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2023-07-10 | Daniel S. Goldman · D-NY | House | Sold | $15,001 - $50,000 |
| 2023-03-31 | Daniel S. Goldman · D-NY | House | Sold | $15,001 - $50,000 |
| 2023-02-27 | Daniel S. Goldman · D-NY | House | Bought | $15,001 - $50,000 |
| 2023-01-13 | Daniel S. Goldman · D-NY | House | Bought | $1,001 - $15,000 |
| 2020-11-13 | Greg Gianforte · R-MT | House | Sold | $50,001 - $100,000 |
| 2019-04-11 | Donna E. Shalala · D-FL | House | Sold | $1,001 - $15,000 |
| 2019-02-15 | Donna E. Shalala · D-FL | House | Bought | $1,001 - $15,000 |
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.